Document Detail


Effect of N-acetylcysteine on cystatin C-based renal function after elective coronary angiography (ENABLE Study): a prospective, randomized trial.
MedLine Citation:
PMID:  18793808     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Several studies have reported the role of N-acetylcysteine on the prevention of contrast induced nephropathy (CIN) with conflicting results. To date, the effect of acetylcysteine on cystatin C-based CIN has not been described. This study was designed to examine the incidence of cystatin C-based CIN and investigate the effect of N-acetylcysteine on the prevention of CIN after coronary angiography (CAG). METHODS: We conducted a prospective, randomized trial on 166 patients (80 patients in N-acetylcysteine group and 86 patients in control group) that underwent elective CAG with apparently normal renal function. Serum cystatin C and creatinine concentrations were measured before, and at 24 and 48 h after CAG. RESULTS: The overall incidence of cystatin C-based CIN among all study subjects was 10.2% (5.0% in N-acetylcysteine group and 15.1% in control group, p<0.05) and that of serum creatinine-based CIN was 6% (3.8% in N-acetylcysteine group and 8.1% in control group, p=NS). Kappa analysis between cystatin C-based CIN and serum creatinine-based CIN showed a substantial agreement (k=0.64). Multivariate logistic regression analysis showed that N-acetylcysteine administration was independently protective against the development of cystatin C-based CIN (Odd ratio[95% confidence interval] 0.255[0.066 to 0.994]) but there was a trend toward protection against that of serum creatinine-based CIN. CONCLUSIONS: This study suggests that in patients with apparently normal renal function, prophylactic oral N-acetylcysteine administration is effective at preventing cystatin C-based CIN development after elective coronary angiography and/or intervention, and that serum cystatin C might be a more sensitive marker of the early CIN than serum creatinine.
Authors:
Byung Jin Kim; Ki Chul Sung; Bum Soo Kim; Jin Ho Kang; Kyu Beck Lee; Hyang Kim; Man Ho Lee
Related Documents :
10914778 - D-xylose kinetics and hydrogen breath tests in functionally anephric patients using the...
8190328 - Immunosuppressive therapy with cyclophosphamide and prednisolone in severe idiopathic m...
897578 - Compensatory renal hypertrophia in patients undergoing unilateral nephrectomy.
19948518 - Effects of dexamethasone on pulmonary and renal functions in patients undergoing cabg w...
19861008 - Assessment of global capacity to conduct tuberculosis drug development trials: do we ha...
18503898 - Midterm outcomes of endovascular repair with the zenith endovascular graft: does the ip...
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial     Date:  2008-09-14
Journal Detail:
Title:  International journal of cardiology     Volume:  138     ISSN:  1874-1754     ISO Abbreviation:  Int. J. Cardiol.     Publication Date:  2010 Feb 
Date Detail:
Created Date:  2010-02-01     Completed Date:  2010-04-13     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8200291     Medline TA:  Int J Cardiol     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  239-45     Citation Subset:  IM    
Copyright Information:
Copyright 2008 Elsevier Ireland Ltd. All rights reserved.
Affiliation:
Division of Cardiology, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, 108 Pyung-Dong, Jongro-Gu, Seoul, 110-746 Republic of Korea. bjjake.kim@samsung.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acetylcysteine / administration & dosage*
Administration, Oral
Aged
Biological Markers / blood
Contrast Media / adverse effects*
Coronary Angiography / adverse effects*,  statistics & numerical data
Creatinine / blood
Cystatin C / blood*
Female
Free Radical Scavengers / administration & dosage
Humans
Incidence
Kidney Diseases / chemically induced*,  epidemiology,  prevention & control*
Kidney Function Tests
Male
Middle Aged
Multivariate Analysis
Prospective Studies
Regression Analysis
Chemical
Reg. No./Substance:
0/Biological Markers; 0/Contrast Media; 0/Cystatin C; 0/Free Radical Scavengers; 60-27-5/Creatinine; 616-91-1/Acetylcysteine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Right atrium contractility and right ventricular diastolic function assessed by pulsed tissue Dopple...
Next Document:  The long-term effects of acute triggers of acute coronary syndromes on adaptation and quality of lif...